Emergent ‘on track’ with COVID-19 vaccine production obligations, J&J takes control of Baltimore plant Emergent BioSolutions Inc yesterday reported that is on target in terms of all its commitments for COVID-19 vaccine production; it also reaffirmed its financial guidance, after a production issue at its Baltimore plant last week saw a massive batch of Johnson & Johnson’s COVID-19 vaccine doses spoiled.
The contract development and manufacturing organization (CDMO) has been producing both the J&J and AstraZeneca vaccines, but mixed up ingredients from the two, causing the loss of 15 million doses, according to the New York Times.
July 2020 saw Emergent sign off on a
Anglo American News Headlines AAL Share News Financial News Articles for Anglo American Plc Ord Usd0 54945 updated throughout the day
lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.
By Bill Galluccio
Jan 7, 2021
The U.S. Department of Health & Human Service is advising states that they can give the COVID-19 vaccines to people who are in lower-priority groups if the doses are going unused.
Distribution of the vaccines has gone slower than anticipated, and many states have vials of the vaccine sitting unused as they work to vaccinate front-line healthcare workers and patients living in long-term care facilities first.
The Centers for Disease Control and Prevention said that more than 17 million vaccines have been sent to the states, but just 5.3 million people have been given the initial injection. Long-term care facilities have received 3.4 million doses but have only vaccinated a little over 500,000 people.
By Bill Galluccio
Jan 7, 2021
The U.S. Department of Health & Human Service is advising states that they can give the COVID-19 vaccines to people who are in lower-priority groups if the doses are going unused.
Distribution of the vaccines has gone slower than anticipated, and many states have vials of the vaccine sitting unused as they work to vaccinate front-line healthcare workers and patients living in long-term care facilities first.
The Centers for Disease Control and Prevention said that more than 17 million vaccines have been sent to the states, but just 5.3 million people have been given the initial injection. Long-term care facilities have received 3.4 million doses but have only vaccinated a little over 500,000 people.
By Bill Galluccio
Jan 7, 2021
The U.S. Department of Health & Human Service is advising states that they can give the COVID-19 vaccines to people who are in lower-priority groups if the doses are going unused.
Distribution of the vaccines has gone slower than anticipated, and many states have vials of the vaccine sitting unused as they work to vaccinate front-line healthcare workers and patients living in long-term care facilities first.
The Centers for Disease Control and Prevention said that more than 17 million vaccines have been sent to the states, but just 5.3 million people have been given the initial injection. Long-term care facilities have received 3.4 million doses but have only vaccinated a little over 500,000 people.
vimarsana © 2020. All Rights Reserved.